Patent · US Active

Alkylating agent combinations in the treatment of cancer

US8716346B2 · kind B2 · utility

1Cited by

5References

20Claims

0Family size

Assignee

CASE WESTERN RESERVE UNIVERSITY · US

Inventors

Stanton Gerson · Hunting Valley, US
Lili Liu · Beijing, CN

Key dates

Filing date	Jul 22, 2011
Grant date	May 6, 2014
Priority date	—
Expiry date	Nov 24, 2031

Classification

Technology area (CPC A)Human Necessities
CPC primaryA61P35/00
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application provides compositions and methods useful in the treatment of certain cancers. In part, this application is based on the recognition that certain molecules that target abasic lesions or AP sites in DNA improve, augment, or potentiate the chemotherapeutic efficacy of certain anticancer agents.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.